Progress of mesenchymal stem cells in treatment of chronic obstructive pulmonary disease

doi:10.11915/j.issn.1671-5403.2025.05.083

Home > Archive>Volume 24, Issue 5, 2025 >397-400. DOI:10.11915/j.issn.1671-5403.2025.05.083

Progress of mesenchymal stem cells in treatment of chronic obstructive pulmonary disease
DOI:
                        10.11915/j.issn.1671-5403.2025.05.083
                    
CSTR:
                        
                    
Author:
                        Chen Ye1Chen Ye
First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
Wang Xuehui2Wang Xuehui
Department of Respiratory Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
Li Zhuying2Li Zhuying
Department of Respiratory Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:(1. First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China;2. Department of Respiratory Medicine, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150040, China)
Clc Number:
Fund Project:This work was supported by the Backup Leader Project for Leading Talent Team of Heilongjiang Province [(2021) 296], the Construction Project of Second Batch Provincial Famous Traditional Chinese Medicine Expert Inheritance Workstation of Heilongjiang Province[(2021) 24] and the Cultivation Program for Young Qihuang Scholars of Heilongjiang Province (2023).

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Abstract:

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory disease characterized by airflow limitation and an accelerated progressive decline in lung function, with manifestations of hypersecretion of mucus, thickening of the airway walls and destruction of alveolus, and its common outcome is pulmonary heart disease. Conventional treatments are not effective in inhibiting its progression. Mesenchymal stem cells (MSCs) can be induced to differentiate into type Ⅱ alveolar epithelial cells, and have the functions of multi-directional differentiation, anti-inflammatory, immune regulation, manipulation and recovery of adjacent cell function, showing application value in the treatment of COPD. In this article, we reviewed and analyzed the action mechanism, administration routes and clinical studies of MSCs in the treatment of COPD in order to better understand the potential and the feasibility of clinical application of MSCs.

Key words:chronic obstructive pulmonary disease; mesenchymal stem cells; cell therapy; clinical application

Get Citation

Copy

Article Metrics

Abstract:
PDF:
HTML:
Cited by:

History

Received:May 30,2024
Revised:
Adopted:
Online: May 22,2025
Published:

Home

About Journal

Editorial Board

Instructions for Authors

Archive

Subscription

Contact Us

Chinese

Get Citation

Related Videos

Share

Article Metrics

History

Article QR Code